Skip to main content

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

Mullen Group Ltd. (MTL-T) says it’s buying the Canadian Industrial Services division of AECOM (ACM-N), which operates largely within the heavy oil and oil sands regions of Alberta. It said the acquisition is expected to add approximately $70-million in annual revenue to Mullen Group.

**

Story continues below advertisement

The Green Organic Dutchman Holdings Ltd. (TGOD-T) says its wholly-owned subsidiary, Medican Organic Inc. has received its cultivation licence from Health Canada for the company’s breeding facility in Salaberry-de-Valleyfield, Que. “The commissioning of this facility will allow the Company to create proprietary, organically grown strains of cannabis and cannabis seeds,” it stated.

**

Nautilus Minerals Inc. (NUS-T) says it has entered into a loan agreement with Deep Sea Mining Finance Ltd.. which formalizes its previously disclosed secured structured credit facility of up to US$34 million.

**

WeedMD Inc. (WMD-X) says it has secured its Health Canada cultivation licence for the first four grow rooms within the first phase of its retrofit of a greenhouse in Strathroy, Ont.

“With a fully-funded 220,000-square-foot retrofit in its final stage, the company will progressively bring a total of 20 grow rooms online over the coming months,” it stated.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies